VO2max as a longevity marker: what the cohort data actually say, and what they do not

Key takeaways

• VO2max correlates with all-cause mortality across multiple large cohorts (Mandsager 2018: 122,007 adults, Imboden 2019: 13,535 adults, Kokkinos 2022: 750,302 US Veterans). The dose-response is steep at the low end and continues into elite ranges.
• Each 1-MET higher cardiorespiratory fitness associates with approximately 11 percent lower all-cause mortality after adjustment for traditional risk factors.
• Sedentary subjects (lowest fitness quartile) had 5x mortality hazard versus elite-fitness subjects in Mandsager 2018 (Cleveland Clinic referral cohort).
• Cohort association is not causation; Mendelian randomization studies are consistent with a causal contribution but precise effect-size estimation requires a randomized trial that is not ethically tractable.
• Training raises VO2max reliably in untrained adults (15-25 percent over 6-12 weeks) . HIIT (4x4 min protocols) and MICT both work; total volume matters more than the specific protocol within a sensible range.

The cohort finding, simply stated

Cardiorespiratory fitness, measured directly as VO2max or estimated from a graded exercise test, sits on a strong gradient with all-cause mortality across multiple large cohorts. The hazard ratios are large enough that fitness is one of the more robust correlates of long-term mortality outside of established disease and smoking .

The finding has been reproduced in occupational cohorts, clinical referral cohorts, and population samples across decades. The shape of the curve is roughly continuous: there is no clean threshold above which mortality risk plateaus, and the steepest part of the curve sits between low and moderate fitness rather than between elite and merely high.

Named cohort studies

• Mandsager et al. JAMA Network Open 2018: 122,007 adults referred for treadmill testing at Cleveland Clinic; elite cardiorespiratory fitness (>2 SD above mean) was associated with the lowest all-cause mortality across all comparisons. The hazard for sedentary subjects (lowest quartile) versus elite was 5.04, exceeding the hazard for end-stage renal disease versus reference. Notably, no upper limit of fitness produced increased mortality .
• Imboden et al. Mayo Clin Proc 2019: 13,535 adult Ball State Adult Fitness Program participants followed prospectively; each 1-MET higher CRF associated with 11 percent lower all-cause mortality after adjustment for traditional risk factors .
• Strasser and Burtscher Front Physiol 2018: meta-analytic synthesis of CRF dose-response curves; consistently steep at low CRF, flatter at high CRF .
• Lee et al. Circulation 2011: 14,345 men in the Aerobics Center Longitudinal Study; improved CRF over 6 years (versus stable or declining CRF) associated with lower mortality, supporting the directionality argument.
• Kokkinos et al. JAMA Netw Open 2022: 750,302 US Veterans cohort; CRF dose-response with all-cause mortality replicated in a nationally distributed cohort.

Absolute VO2max by age and sex

VO2max declines with age in roughly linear fashion. Population reference values from the FRIEND registry (Fitness Registry and the Importance of Exercise National Database) provide age- and sex-specific percentiles :

• Men age 30-39: 50th percentile ~38 mL/kg/min; 90th percentile ~55 mL/kg/min.
• Men age 50-59: 50th percentile ~32 mL/kg/min; 90th percentile ~45 mL/kg/min.
• Men age 70+: 50th percentile ~22 mL/kg/min; 90th percentile ~35 mL/kg/min.
• Women age 30-39: 50th percentile ~32 mL/kg/min; 90th percentile ~45 mL/kg/min.
• Women age 50-59: 50th percentile ~25 mL/kg/min; 90th percentile ~36 mL/kg/min.
• Women age 70+: 50th percentile ~17 mL/kg/min; 90th percentile ~26 mL/kg/min.

Elite endurance athletes typically reach 70-90 mL/kg/min; the highest reported values approach 100 mL/kg/min in elite cross-country skiers. The mortality gradient is steepest in the lower deciles where small increases produce large absolute risk reductions.

Association is not causation

Cohort designs cannot, by themselves, prove that raising VO2max causes lower mortality. The same person who runs 30 miles a week is also more likely to sleep more, smoke less, and have lower visceral adiposity. Statistical adjustment helps but never fully resolves confounding. This is a familiar problem in observational epidemiology, and it has been documented carefully in causal-inference literature .

Mendelian randomization studies have begun to triangulate the causal direction by using genetic variants as instruments for cardiorespiratory fitness or physical activity. The results so far are consistent with a causal contribution, but they cannot estimate the population-level effect size with the precision a true randomized trial would .

Mortality-endpoint randomized trials of exercise versus no-exercise control are not feasible in healthy adults: the trial duration required is decades, the contamination across arms is high (control subjects do not stay sedentary for decades), and there is no equipoise (no IRB will randomize someone to a known-harmful exposure for the comparator arm). The causal claim therefore rests on Mendelian randomization, mechanistic biology, and the consistency of the cohort signal across populations and decades.

What actually raises VO2max

• Sustained aerobic training that pushes the upper end of sustainable intensity. Both moderate-intensity continuous training and interval-based protocols produce VO2max gains in randomized trials.
• High-intensity interval training (HIIT, 4x4 minute intervals at 85-95 percent HR max) produces approximately 20-25 percent VO2max gains over 8-12 weeks in untrained subjects in trials by Helgerud, Wisloff, and others .
• Initial gains in untrained adults can reach 15 to 25 percent over 6 to 12 weeks . Diminishing returns set in, and trained athletes may plateau within a much narrower band (1-3 percent additional gains per year are typical for already-trained subjects).
• Cross-modal exposure (running plus cycling, or rowing) tends to be better tolerated than single-mode high volume.
• Standing weekly training volume matters more than the specific protocol within a sensible range, in head-to-head trials. Standard physical-activity guidelines recommend at least 150 minutes/week of moderate-intensity or 75 minutes/week of vigorous-intensity aerobic activity for substantial general-health benefits ; note these are health-outcome minimums, not a CRF-gain threshold, since VO2max improvement is driven more by intensity and progressive overload and occurs across a wide range of weekly volumes.
• Genetic ceiling exists but is typically not reached without trained adult years of consistent training; population data place the ceiling above what most adults achieve.

Training zones and the 'zone 2' conversation

Endurance training is conventionally framed in zones (1-5 by heart rate or power) corresponding to physiological intensities below and above the lactate thresholds. The popularized 'zone 2' (typically 60-70 percent of max HR, just below first lactate threshold) is the pace at which mitochondrial biogenesis adaptations are maximized for trained-athlete polarization. The Seiler polarization research (Seiler 2010, Esteve-Lanao 2007) supports an 80/20 distribution of low-intensity to high-intensity training in elite endurance athletes .

For non-elite adults trying to raise VO2max from baseline, the simpler framing is: include some moderate-intensity volume (zones 2-3) and some genuinely hard intervals (zone 4-5) within a weekly schedule. The polarization optimization matters more for elite athletes than for adults trying to move the cohort-mortality needle.

Where peptides and pharmacology fit

There is no FDA-approved peptide or small molecule that durably raises VO2max in healthy adults. The mitochondrial-biogenesis literature includes preclinical work on AMPK activators, PPARδ agonists (cardarine / GW-501516, which is WADA-prohibited and has documented preclinical carcinogenicity signals ), and ERR agonists (the SLU-PP-332 line of preclinical compounds). None of those has a controlled human VO2max trial supporting use.

EPO (erythropoietin) and blood doping raise oxygen-carrying capacity and therefore measured VO2max, but they are WADA-prohibited and carry meaningful cardiovascular risk; they are not a longevity intervention. Iron supplementation in iron-deficient individuals raises VO2max by addressing a deficit; it does not raise VO2max in iron-replete individuals.

Editorial summary

VO2max is one of the most consistently mortality-correlated single measurements in observational medicine. The causal proof at the mortality endpoint rests on Mendelian randomization plus mechanism plus dose-response consistency across cohorts. Training raises VO2max reliably in untrained adults; the durability across years is what the cohort data actually capture. No drug or peptide replaces structured training as a CRF lever in healthy adults.

Related tools

• Protocol builder overview - Public overview of the Pro protocol builder.